Viemed Healthcare
VMD
112 hedge funds and large institutions have $159M invested in Viemed Healthcare in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 10 closing their positions.
400% more call options, than puts
Call options by funds: $5K | Put options by funds: $1K
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
15% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 33
9% more funds holding
Funds holding: 103 → 112 (+9)
2.2% less ownership
Funds ownership: 63.51% → 61.31% (-2.2%)
36% less capital invested
Capital invested by funds: $246M → $159M (-$87.7M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
Top Sellers
VMD Hedge Fund Activity: Q3 2023 in Review
112 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2023, worth a combined $159M — down 36% from $246M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VMD positions and 10 closed out — a net gain of 10 holders — while 38 added to existing stakes and 33 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $2.49M. The largest seller was Hillsdale Investment Management, cutting an estimated $5.66M.
- 112 institutional investors held Viemed Healthcare (VMD) as of Q3 2023, up from 103 in Q2 2023.
- Funds reported $159M of Viemed Healthcare stock for Q3 2023, down 36% quarter-over-quarter.
- 20 funds opened new Viemed Healthcare positions in Q3 2023 and 10 closed out, a net change of +10 holders.
- The largest Viemed Healthcare buyer in Q3 2023 was Nantahala Capital Management, an estimated $2.49M added.
- The largest Viemed Healthcare seller in Q3 2023 was Hillsdale Investment Management, an estimated $5.66M sold.
Based on aggregated 13F filings for Q3 2023.